SCHEMBL25975832

SCHEMBL25975832

Cc1cnc2c(c1)CN(CCO)CC2

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDCD1 Q15116 7/20 0.42
CD274 Q9NZQ7 7/20 0.42
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
LMNA P02545 3/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 4/20 0.38
CYP2C19 P33261 1/20 0.38
JAK2 O60674 2/20 0.37
FLT3 P36888 1/20 0.37
CDK1 P06493 1/20 0.36
CDK4 P11802 1/20 0.36
CDK2 P24941 1/20 0.36
CDK7 P50613 1/20 0.36
CDK9 P50750 1/20 0.36
CDK6 Q00534 1/20 0.36
TP53 P04637 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21622307 0.88 JAK2 (0.34) PDCD1CD274ADORA2AADORA1LMNA
SCHEMBL25975830 0.82 LMNA (0.40) ADORA2AADORA1LMNAPOLBMAPT
SCHEMBL14566140 0.82 ADORA2A (0.40) ADORA2AADORA1LMNAPOLBMAPT
SCHEMBL14566143 0.82 CDK4 (0.41) ADORA2AADORA1LMNAPOLBMAPT
SCHEMBL18098800 0.80 ADORA2A (0.39) ADORA2AADORA1LMNAPOLBMAPT
SCHEMBL31362283 0.79 PDCD1 (0.38) PDCD1CD274LMNAMAPTCYP2C19
SCHEMBL14853093 0.79 CYP2C19 (0.45) ADORA2AADORA1LMNAPOLBMAPT
SCHEMBL25975828 0.78 CDK4 (0.38) ADORA2AADORA1LMNAPOLBMAPT
SCHEMBL26032299 0.78 POLB (0.41) ADORA2AADORA1LMNAPOLBMAPT
SCHEMBL14853336 0.78 HRH3 (0.37) ADORA2AADORA1LMNAPOLBCDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154282-A1 COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS THERAS, INC. (US) 2023-08-17 WO disclosed